These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19303979)

  • 21. Analysis of apolipoprotein A5, c3, and plasma triglyceride concentrations in genetically engineered mice.
    Baroukh N; Bauge E; Akiyama J; Chang J; Afzal V; Fruchart JC; Rubin EM; Fruchart-Najib J; Pennacchio LA
    Arterioscler Thromb Vasc Biol; 2004 Jul; 24(7):1297-302. PubMed ID: 15117734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences during the course of diet-induced obesity in mice: adipose tissue expandability and glycemic control.
    Medrikova D; Jilkova ZM; Bardova K; Janovska P; Rossmeisl M; Kopecky J
    Int J Obes (Lond); 2012 Feb; 36(2):262-72. PubMed ID: 21540832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. APOA5 genotype modulates 2-y changes in lipid profile in response to weight-loss diet intervention: the Pounds Lost Trial.
    Zhang X; Qi Q; Bray GA; Hu FB; Sacks FM; Qi L
    Am J Clin Nutr; 2012 Oct; 96(4):917-22. PubMed ID: 22914552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CTRP3 deficiency reduces liver size and alters IL-6 and TGFβ levels in obese mice.
    Wolf RM; Lei X; Yang ZC; Nyandjo M; Tan SY; Wong GW
    Am J Physiol Endocrinol Metab; 2016 Mar; 310(5):E332-45. PubMed ID: 26670485
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in mice.
    Xepapadaki E; Maulucci G; Constantinou C; Karavia EA; Zvintzou E; Daniel B; Sasson S; Kypreos KE
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1351-1360. PubMed ID: 30742993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin ameliorates obesity-associated hypertriglyceridemia in mice partly through the apolipoprotein A5 pathway.
    Li R; Chen LZ; Zhao W; Zhao SP; Huang XS
    Biochem Biophys Res Commun; 2016 Sep; 478(3):1173-8. PubMed ID: 27544029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased production of very-low-density lipoproteins in transgenic mice overexpressing human apolipoprotein A-II and fed with a high-fat diet.
    Julve J; Escolà-Gil JC; Marzal-Casacuberta A; Ordóñez-Llanos J; González-Sastre F; Blanco-Vaca F
    Biochim Biophys Acta; 2000 Nov; 1488(3):233-44. PubMed ID: 11082533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.
    Pennacchio LA; Olivier M; Hubacek JA; Krauss RM; Rubin EM; Cohen JC
    Hum Mol Genet; 2002 Nov; 11(24):3031-8. PubMed ID: 12417524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term overexpression of glucokinase in the liver of transgenic mice leads to insulin resistance.
    Ferre T; Riu E; Franckhauser S; Agudo J; Bosch F
    Diabetologia; 2003 Dec; 46(12):1662-8. PubMed ID: 14614559
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans.
    Hahne P; Krempler F; Schaap FG; Soyal SM; Höffinger H; Miller K; Oberkofler H; Strobl W; Patsch W
    J Intern Med; 2008 Nov; 264(5):452-62. PubMed ID: 18537870
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apolipoprotein A5 and hypertriglyceridemia in Prague hypertriglyceridemic rats.
    Kadlecová M; Hojná S; Bohuslavová R; Hubácek JA; Zicha J; Kunes J
    Physiol Res; 2006; 55(4):373-379. PubMed ID: 16238453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-mediated down-regulation of apolipoprotein A5 gene expression through the phosphatidylinositol 3-kinase pathway: role of upstream stimulatory factor.
    Nowak M; Helleboid-Chapman A; Jakel H; Martin G; Duran-Sandoval D; Staels B; Rubin EM; Pennacchio LA; Taskinen MR; Fruchart-Najib J; Fruchart JC
    Mol Cell Biol; 2005 Feb; 25(4):1537-48. PubMed ID: 15684402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges.
    Martin S; Nicaud V; Humphries SE; Talmud PJ;
    Biochim Biophys Acta; 2003 Apr; 1637(3):217-25. PubMed ID: 12697303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of apolipoprotein A-V on plasma triglyceride, lipoprotein size, and composition in genetically engineered mice.
    Nelbach L; Shu X; Konrad RJ; Ryan RO; Forte TM
    J Lipid Res; 2008 Mar; 49(3):572-80. PubMed ID: 18056685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The liver X receptor ligand T0901317 down-regulates APOA5 gene expression through activation of SREBP-1c.
    Jakel H; Nowak M; Moitrot E; Dehondt H; Hum DW; Pennacchio LA; Fruchart-Najib J; Fruchart JC
    J Biol Chem; 2004 Oct; 279(44):45462-9. PubMed ID: 15317819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perilipin overexpression in mice protects against diet-induced obesity.
    Miyoshi H; Souza SC; Endo M; Sawada T; Perfield JW; Shimizu C; Stancheva Z; Nagai S; Strissel KJ; Yoshioka N; Obin MS; Koike T; Greenberg AS
    J Lipid Res; 2010 May; 51(5):975-82. PubMed ID: 19797618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Apolipoprotein A5 and triglyceridemia. Focus on the effects of the common variants.
    Hubacek JA
    Clin Chem Lab Med; 2005; 43(9):897-902. PubMed ID: 16176166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
    Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
    Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APOA5-1131T>C polymorphism is associated with triglyceride levels in Chinese men.
    Baum L; Tomlinson B; Thomas GN
    Clin Genet; 2003 May; 63(5):377-9. PubMed ID: 12752569
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The frog skin host-defense peptide CPF-SE1 improves glucose tolerance, insulin sensitivity and islet function and decreases plasma lipids in high-fat fed mice.
    Srinivasan D; Ojo OO; Owolabi BO; Conlon JM; Flatt PR; Abdel-Wahab YHA
    Eur J Pharmacol; 2015 Oct; 764():38-47. PubMed ID: 26123844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.